156 related articles for article (PubMed ID: 18997663)
1. Cetuximab: potential role as first-line treatment for advanced non-small cell lung cancer.
Pirker R
Clin Adv Hematol Oncol; 2008 Oct; 6(10):735-6. PubMed ID: 18997663
[No Abstract] [Full Text] [Related]
2. Cetuximab in non-small-cell lung cancer.
Carillio G; Montanino A; Costanzo R; Sandomenico C; Piccirillo MC; Di Maio M; Daniele G; Giordano P; Bryce J; Normanno N; Rocco G; Perrone F; Morabito A
Expert Rev Anticancer Ther; 2012 Feb; 12(2):163-75. PubMed ID: 22316364
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies against EGFR in non-small cell lung cancer.
Pirker R; Filipits M
Crit Rev Oncol Hematol; 2011 Oct; 80(1):1-9. PubMed ID: 21109448
[TBL] [Abstract][Full Text] [Related]
4. Targeting the epidermal growth factor receptor a new strategy in cancer treatment.
Gianni L; Grasselli G
Suppl Tumori; 2002; 1(4):S60-1. PubMed ID: 12415824
[No Abstract] [Full Text] [Related]
5. Cetuximab in advanced non-small cell lung cancer.
Rossi A; Maione P; Gridelli C
Crit Rev Oncol Hematol; 2006 Aug; 59(2):139-49. PubMed ID: 16806963
[TBL] [Abstract][Full Text] [Related]
6. Is there a role for cetuximab in non small cell lung cancer?
Morgensztern D; Govindan R
Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4602-5. PubMed ID: 17671149
[TBL] [Abstract][Full Text] [Related]
7. Will FLEX allow us flexibility in the therapy of advanced non-small-cell lung cancer? Insights from the 2008 American Society of Clinical Oncology Meeting.
Langer CJ
Clin Lung Cancer; 2008 Sep; 9(5):249-51. PubMed ID: 18824445
[No Abstract] [Full Text] [Related]
8. Can epidermal growth factor receptor-fluorescent in situ hybridization predict clinical benefit from cetuximab treatment in patients with non-small-cell lung cancer?
Takano T; Ota S; Hori A; Seki N; Eguchi K
J Clin Oncol; 2009 Jan; 27(3):464-5; author reply 465-7. PubMed ID: 19064956
[No Abstract] [Full Text] [Related]
9. Gefitinib versus cetuximab in lung cancer: round one.
Minna JD; Peyton MJ; Gazdar AF
J Natl Cancer Inst; 2005 Aug; 97(16):1168-9. PubMed ID: 16106015
[No Abstract] [Full Text] [Related]
10. Epidermal growth factor receptor as a target in cancer therapy.
Kim ES
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S87-95. PubMed ID: 19795581
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer: looking ahead in 2004.
Belani CP; Ramalingam S
Clin Lung Cancer; 2004 Jan; 5(4):200. PubMed ID: 14967070
[No Abstract] [Full Text] [Related]
12. Cetuximab in advanced non-small cell lung cancer.
Govindan R
Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4241s-4244s. PubMed ID: 15217966
[TBL] [Abstract][Full Text] [Related]
13. New treatment strategies in patients with advanced non-small-cell lung cancer and performance status 2.
Rodriguez E; Lilenbaum RC
Clin Lung Cancer; 2008 Nov; 9(6):326-30. PubMed ID: 19073514
[TBL] [Abstract][Full Text] [Related]
14. The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancer.
Langer C; Soria JC
Clin Lung Cancer; 2010 Mar; 11(2):82-90. PubMed ID: 20199973
[TBL] [Abstract][Full Text] [Related]
15. The evolving role of cetuximab in non-small cell lung cancer.
Lilenbaum RC
Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4432s-4435s. PubMed ID: 16857823
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancer.
Agelaki S; Georgoulias V
Expert Opin Emerg Drugs; 2005 Nov; 10(4):855-74. PubMed ID: 16262567
[TBL] [Abstract][Full Text] [Related]
17. Update on HER1-3 in advanced non-small-cell lung cancer.
Horn L; Lovly C
J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S369-71. PubMed ID: 23160321
[No Abstract] [Full Text] [Related]
18. Is there still room for large registrative trials in unselected cancer patients? The case of anti-epidermal growth factor receptor antibodies in advanced non-small-cell lung cancer.
Di Maio M
Expert Opin Biol Ther; 2011 Sep; 11(9):1131-3. PubMed ID: 21806477
[TBL] [Abstract][Full Text] [Related]
19. Exploring the future of non-small cell lung cancer treatment.
Ramalingam S
Manag Care; 2005 Feb; 14(2 Suppl):9-13; discussion 13-4. PubMed ID: 15776956
[No Abstract] [Full Text] [Related]
20. Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer.
Kotsakis A; Georgoulias V
Expert Opin Pharmacother; 2010 Oct; 11(14):2363-89. PubMed ID: 20586711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
